- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.05. | Syra Health GAAP EPS of -$0.04, revenue of $1.86M | 1 | Seeking Alpha | ||
| 08.05. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Syra Health Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY | 51 | PR Newswire | Revenue increase led by Population Health's 261% YoY Expansion
Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY
Continued Efficiency Gains... ► Artikel lesen | |
| 08.04. | Syra Health Corp - 8-K, Current Report | 4 | SEC Filings | ||
| 01.04. | Syra Health announces voluntary delisting from Nasdaq | 4 | Seeking Alpha | ||
| 01.04. | Syra Health to delist from Nasdaq Capital Market | 1 | Investing.com | ||
| SYRA HEALTH Aktie jetzt für 0€ handeln | |||||
| 01.04. | Syra Health kündigt Rückzug vom NASDAQ Capital Market an | 2 | Investing.com Deutsch | ||
| 01.04. | Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market | 74 | PR Newswire | CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen | |
| 13.03. | Syra Health sichert Vertragsverlängerung im Wert von 660.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 13.03. | Syra Health secures $660,000 population health contract extension | 1 | Seeking Alpha | ||
| 11.03. | Syra Health Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 11.03. | Syra Health Corp - 10-K, Annual Report | 1 | SEC Filings | ||
| 11.03. | Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY | 209 | PR Newswire | 2024 Population Health Revenue Acceleration to 132% YoY
Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains
Continued... ► Artikel lesen | |
| 11.03. | Syra Health GAAP EPS of -$0.50, revenue of $7.98M | 1 | Seeking Alpha | ||
| 25.02. | Syra Health secures $450K contract extension in Tennessee | 2 | Investing.com | ||
| 13.02. | Syra Health sichert sich neuen Vertrag für Schulungen im Bereich psychische Gesundheit | 2 | Investing.com Deutsch | ||
| 24.01. | Syra Health files for $75M mixed securities shelf | 1 | Seeking Alpha | ||
| 17.01. | Syra Health Corp - 8-K, Current Report | - | SEC Filings | ||
| 07.01. | Why Is Syra Health Stock Surging Today? | 1 | Benzinga.com |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,129 | -1,53 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
| ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,802 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,244 | -10,95 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,697 | -6,82 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,450 | -1,19 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,465 | 0,00 % | VOLITIONRX LTD - 10-Q, Quarterly Report | ||
| EKSO BIONICS | 0,430 | +8,04 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Accepted into NVIDIA Connect Program | ||
| IMUNON | 0,540 | +8,00 % | Imunon, Inc.: IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 | Company's PlaCCine® technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications... ► Artikel lesen | |
| BEYOND AIR | 0,170 | +6,25 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| NOVACYT | 0,469 | +1,85 % | Novacyt announces AGM scheduled for June 19, 2025 | ||
| AROVELLA THERAPEUTICS | 0,042 | -6,67 % | Biocurious: With its 'molecular Lego' approach, Arovella is building hope for cancer patients one brick at a time |
SYRA HEALTH CORP gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,001 (+0,48 %) liegt der Kurs bei 0,105 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SYRA HEALTH CORP finden Sie auf Wallstreet Online.